A new analysis of data from Chicago shows that as violent crime decreases, so does the area’s death rate from heart disease.

A multi-year partnership brings together two iconic brands with shared goal of making impact on health care in the Philadelphia community.

New research at Penn Medicine shows apremilast could help people with psoriasis shed unhealthy body fat and therefore improve cardiovascular health.

A relative lack of DOPA, and not simply susceptibility to sun damage, helps explain why melanoma is much more common in people with light skin tones.

Making it possible to directly work through patients’ electronic health records for genetic tests resulted in significant time savings for clinicians.

A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer.

Researchers saw a fourfold decline in the rate of patients who needed to go back to the hospital after total hip or knee replacements with home monitoring.

A new four-year program teaches medical students how to effectively communicate with, support, and care for patients with serious illness.

A $4.7 million NIH grant will allow Penn Medicine researchers to help lead development of an algorithm to flag patients at risk of rare diseases.

Bloodstream levels of a protein fragment called endotrophin can be used to predict outcomes in patients with a common form of heart failure.